Copyright Reports & Markets. All rights reserved.

Global Antiretroviral Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Antiretroviral Drug Market Overview

    • 1.1 Product Overview and Scope of Antiretroviral Drug
    • 1.2 Classification of Antiretroviral Drug by Types
      • 1.2.1 Global Antiretroviral Drug Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Antiretroviral Drug Revenue Market Share by Types in 2018
      • 1.2.3 Multi-Class Drugs Combination
      • 1.2.4 NRTI
      • 1.2.5 NNRTI
      • 1.2.6 Protease Inhibitors
      • 1.2.7 Other
    • 1.3 Global Antiretroviral Drug Market by Application
      • 1.3.1 Global Antiretroviral Drug Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Pharmaceutical Companies
      • 1.3.4 Other
    • 1.4 Global Antiretroviral Drug Market by Regions
      • 1.4.1 Global Antiretroviral Drug Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Antiretroviral Drug Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Antiretroviral Drug Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antiretroviral Drug Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Antiretroviral Drug Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antiretroviral Drug Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Antiretroviral Drug (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Gilead Sciences
      • 2.1.1 Business Overview
      • 2.1.2 Antiretroviral Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 ViiV Healthcare
      • 2.2.1 Business Overview
      • 2.2.2 Antiretroviral Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Bristol-Myer Squibb
      • 2.3.1 Business Overview
      • 2.3.2 Antiretroviral Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 AbbVie
      • 2.4.1 Business Overview
      • 2.4.2 Antiretroviral Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Boehringer-Ingelheim
      • 2.5.1 Business Overview
      • 2.5.2 Antiretroviral Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Johnson and Johnson
      • 2.6.1 Business Overview
      • 2.6.2 Antiretroviral Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Merck
      • 2.7.1 Business Overview
      • 2.7.2 Antiretroviral Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 CIPLA
      • 2.8.1 Business Overview
      • 2.8.2 Antiretroviral Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Antiretroviral Drug Market Competition, by Players

    • 3.1 Global Antiretroviral Drug Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Antiretroviral Drug Players Market Share
      • 3.2.2 Top 10 Antiretroviral Drug Players Market Share
    • 3.3 Market Competition Trend

    4 Global Antiretroviral Drug Market Size by Regions

    • 4.1 Global Antiretroviral Drug Revenue and Market Share by Regions
    • 4.2 North America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 4.5 South America Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    5 North America Antiretroviral Drug Revenue by Countries

    • 5.1 North America Antiretroviral Drug Revenue by Countries (2014-2019)
    • 5.2 USA Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    6 Europe Antiretroviral Drug Revenue by Countries

    • 6.1 Europe Antiretroviral Drug Revenue by Countries (2014-2019)
    • 6.2 Germany Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 6.3 UK Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 6.4 France Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Antiretroviral Drug Revenue by Countries

    • 7.1 Asia-Pacific Antiretroviral Drug Revenue by Countries (2014-2019)
    • 7.2 China Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 7.5 India Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    8 South America Antiretroviral Drug Revenue by Countries

    • 8.1 South America Antiretroviral Drug Revenue by Countries (2014-2019)
    • 8.2 Brazil Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Antiretroviral Drug by Countries

    • 9.1 Middle East and Africa Antiretroviral Drug Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Antiretroviral Drug Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Antiretroviral Drug Revenue and Growth Rate (2014-2019)

    10 Global Antiretroviral Drug Market Segment by Type

    • 10.1 Global Antiretroviral Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Antiretroviral Drug Market Forecast by Type (2019-2024)
    • 10.3 Multi-Class Drugs Combination Revenue Growth Rate (2014-2024)
    • 10.4 NRTI Revenue Growth Rate (2014-2024)
    • 10.5 NNRTI Revenue Growth Rate (2014-2024)
    • 10.6 Protease Inhibitors Revenue Growth Rate (2014-2024)
    • 10.7 Other Revenue Growth Rate (2014-2024)

    11 Global Antiretroviral Drug Market Segment by Application

    • 11.1 Global Antiretroviral Drug Revenue Market Share by Application (2014-2019)
    • 11.2 Antiretroviral Drug Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
    • 11.5 Other Revenue Growth (2014-2019)

    12 Global Antiretroviral Drug Market Size Forecast (2019-2024)

    • 12.1 Global Antiretroviral Drug Market Size Forecast (2019-2024)
    • 12.2 Global Antiretroviral Drug Market Forecast by Regions (2019-2024)
    • 12.3 North America Antiretroviral Drug Revenue Market Forecast (2019-2024)
    • 12.4 Europe Antiretroviral Drug Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Antiretroviral Drug Revenue Market Forecast (2019-2024)
    • 12.6 South America Antiretroviral Drug Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Antiretroviral Drug Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Tire-derived fuel (TDF) is composed of shredded scrap tires.

      Scope of the Report:
      The global Antiretroviral Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antiretroviral Drug.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Antiretroviral Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antiretroviral Drug market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Gilead Sciences
      ViiV Healthcare
      Bristol-Myer Squibb
      AbbVie
      Boehringer-Ingelheim
      Johnson and Johnson
      Merck
      CIPLA

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Multi-Class Drugs Combination
      NRTI
      NNRTI
      Protease Inhibitors
      Other

      Market Segment by Applications, can be divided into
      Hospital
      Pharmaceutical Companies
      Other

      Buy now